The global bioengineered protein drugs market is entering a decade of high-velocity growth, with its valuation projected to surge from USD 14.7 billion in 2025 to USD 37.0 billion by 2035. According to a comprehensive strategic outlook by Fact.MR, the industry will expand at a CAGR of 9.7%, fueled by a global mandate to combat non-communicable diseases (NCDs) and...